A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study

authors

• Labreche Karim
• Daniau Mailys
• Sud Amit
• Law Philip J
• Royer-Perron Louis
• Holroyd Amy
• Broderick Peter
• Went Molly
• Benazra Marion
• Ahle Guido
• Soubeyran Pierre
• Taillandier Luc
• Chinot Olivier
• Casasnovas Olivier
• Bay Jacques-Olivier
• Jardin Fabrice
• Oberic Lucie
• Fabbro Michel
• Damaj Gandhi
• Brion Annie
• Mokhtari Karima
• Philippe Cathy
• Sanson Marc
• Houillier Caroline
• Soussain Carole
• Hoang-Xuan Khê
• Houlston Richard
• Alentorn Agusti
• Moles-Moreau Marie-Pierre
• Gressin Rémy
• Morschhauser Franck
• Agapé Philippe
• Jaccard Arnaud
• Ghesquières Hervé
• Tempescul Adrian
• Gyan Emmanuel
• Marolleau Jean-Pierre
• Houot Roch
• Fornecker Luc
• Stefano Anna-Luisa Di
• Detrait Ines
• Rahimian Amithys
• Lathrop Mark
• Genet Diane
• Davi Frederic C
• Cassoux Nathalie
• Touitou Valérie
• Choquet Sylvain
• Vital Anne
• Polivka Marc
• Figarella-Branger Dominique
• Benouaich-Amiel Alexandra
• Campello Chantal
• Charlotte Fréderic
• Martin-Duverneuil Nadine
• Feuvret Loïc
• Kas Aurélie
• Navarro Soledad
• Villa Chiara
• Bielle Franck
• Chrétien Fabrice
• Tortel Marie Christine
• Gauchotte Guillaume
• Uro-Coste Emmanuelle
• Godfrain Catherine
• Rigau Valérie
• Costopoulos Myrto
• Garff-Tavernier Magalie Le
• Meyronnet David
• Rousseau Audrey
• Adam Clovis
• Lamy Thierry
• Chabrot Cécile
• Boyle Eileen
• Blonski Marie
• Schmitt Anna

keywords

• GWAS
• Cancer susceptibility
• Primary CNS lymphoma

document type

abstract

Background: Primary central nervous system lymphoma (PCNSL) is a rare form of extra-nodal non-Hodgkin lymphoma. PCNSL is a distinct subtype of non-Hodgkin lymphoma, with over 95% of tumors belonging to the diffuse large B-cell lymphoma (DLBCL) group. We have conducted a genome-wide association study (GWAS) on immunocompetent patients to address the possibility that common genetic variants influence the risk of developing PCNSL. Methods: We performed a meta-analysis of 2 new GWASs of PCNSL totaling 475 cases and 1134 controls of European ancestry. To increase genomic resolution, we imputed >10 million single nucleotide polymorphisms using the 1000 Genomes Project combined with UK10K as reference. In addition we performed a transcription factor binding disruption analysis and investigated the patterns of local chromatin by Capture Hi-C data. Results: We identified independent risk loci at 3p22.1 (rs41289586, ANO10, P = 2.17 × 10-8) and 6p25.3 near EXOC2 (rs116446171, P = 1.95 x 10-13). In contrast, the lack of an association between rs41289586 and DLBCL suggests distinct germline predisposition to PCNSL and DLBCL. We found looping chromatin interactions between noncoding regions at 6p25.3 (rs11646171) with the IRF4 promoter and at 8q24.21 (rs13254990) with the MYC promoter, both genes with strong relevance to B-cell tumorigenesis. Conclusion: To our knowledge this is the first study providing insight into the genetic predisposition to PCNSL. Our findings represent an important step in defining the contribution of common genetic variation to the risk of developing PCNSL.

more information